每經AI快訊，*ST賽(sai)隆（SZ 002898，收盤價：8.39元）5月19日晚間發布公(gong)(gong)告稱(cheng)，公(gong)(gong)司(si)(si)(si)控(kong)(kong)股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)東(dong)、實際控(kong)(kong)制(zhi)人(ren)蔡南(nan)(nan)桂(gui)先(xian)(xian)生(sheng)(sheng)、唐霖(lin)女(nv)士(shi)于5月18日與海南(nan)(nan)雅億(yi)簽署(shu)了《關(guan)于賽(sai)隆藥業集團股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)限公(gong)(gong)司(si)(si)(si)之(zhi)股(gu)(gu)(gu)(gu)份(fen)(fen)轉讓協議》，蔡南(nan)(nan)桂(gui)先(xian)(xian)生(sheng)(sheng)、唐霖(lin)女(nv)士(shi)擬向海南(nan)(nan)雅億(yi)轉讓其持有(you)的(de)公(gong)(gong)司(si)(si)(si) 14.16%股(gu)(gu)(gu)(gu)份(fen)(fen)（對應(ying)的(de)股(gu)(gu)(gu)(gu)票數量為(wei)(wei)(wei)24,912,205 股(gu)(gu)(gu)(gu)，以下簡稱(cheng)“標的(de)股(gu)(gu)(gu)(gu)份(fen)(fen)”）。同時，蔡南(nan)(nan)桂(gui)先(xian)(xian)生(sheng)(sheng)、唐霖(lin)女(nv)士(shi)承(cheng)諾自本(ben)次(ci)(ci)(ci)交(jiao)易(yi)交(jiao)割(ge)日起至其不(bu)再持有(you)上市(shi)公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)之(zhi)日止(zhi)，無(wu)條件且不(bu)可撤銷地承(cheng)諾放棄行使其所(suo)持標的(de)公(gong)(gong)司(si)(si)(si)剩余股(gu)(gu)(gu)(gu)份(fen)(fen)所(suo)對應(ying)的(de)除收益(yi)權(quan)和(he)股(gu)(gu)(gu)(gu)票處(chu)置權(quan)之(zhi)外的(de)全(quan)部股(gu)(gu)(gu)(gu)東(dong)權(quan)利。標的(de)股(gu)(gu)(gu)(gu)份(fen)(fen)作價為(wei)(wei)(wei)人(ren)民幣 8 元/股(gu)(gu)(gu)(gu)，交(jiao)易(yi)金額(e)共計人(ren)民幣199,297,640.00 元。若(ruo)本(ben)次(ci)(ci)(ci)交(jiao)易(yi)事項(xiang)順利實施并完成(cheng)，公(gong)(gong)司(si)(si)(si)的(de)控(kong)(kong)股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)東(dong)及實際控(kong)(kong)制(zhi)人(ren)將(jiang)發生(sheng)(sheng)變(bian)(bian)更。公(gong)(gong)司(si)(si)(si)的(de)控(kong)(kong)股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)東(dong)將(jiang)變(bian)(bian)為(wei)(wei)(wei)海南(nan)(nan)雅億(yi)，由于目前海南(nan)(nan)雅億(yi)無(wu)實際控(kong)(kong)制(zhi)人(ren)，故(gu)公(gong)(gong)司(si)(si)(si)將(jiang)變(bian)(bian)更為(wei)(wei)(wei)無(wu)實際控(kong)(kong)制(zhi)人(ren)。本(ben)次(ci)(ci)(ci)股(gu)(gu)(gu)(gu)份(fen)(fen)轉讓不(bu)觸及要約收購，不(bu)構成(cheng)關(guan)聯交(jiao)易(yi)。 

2024年1至12月份，*ST賽隆的營業(ye)收入構成(cheng)為：醫藥制(zhi)造業(ye)占(zhan)比99.05%，其他業(ye)務占(zhan)比0.95%。

截至發稿，*ST賽(sai)隆市值為15億(yi)元(yuan)。

每經頭條（nbdtoutiao）——

（記者 胡玲）

免責聲明：本文內容與數據(ju)僅供參(can)考，不(bu)構成投資建(jian)議，使用前請核(he)實(shi)。據(ju)此操(cao)作(zuo)，風險自擔(dan)。